Cite Filings / MYGN / 0001564590-19-027726
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
8-K

Current Report

MYRIAD GENETICS INC · Filed 2019-08-01 · Acc 0001564590-19-027726

Other events

  • Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , mygn-8k_20190801.htm

Around this filing

  • 2019-08-13 8-K Results of operations · Regulation FD disclosure
  • 2019-08-02 4 President Crescendo BioScience sold 11,712 shares at $40.00 ($468,480)
  • 2019-08-02 4 Chief Financial Officer sold 25,000 shares at $41.50 ($1,037,575)
  • 2019-08-02 4 Exec. VP International Ops sold 60,000 shares at an average $43.49 ($2,609,329)
  • 2019-08-02 4 President & C.E.O. sold 137,000 shares at $44.00 ($6,028,000)
  • 2019-08-01 8-K Other events
  • 2019-07-19 8-K Other events

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading mygn-8k_20190801.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…